Shares of healthcare services company Select Medical (NYSE:SEM) fell 14.1% in the morning session after the company reported disappointing fourth quarter 2024 results, which missed across all key operating metrics. Its full-year revenue and EBITDA guidance also fell short of Wall Street's estimates. Overall, this was a weaker quarter.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Select Medical? Access our full analysis report here, it’s free.
Select Medical’s shares are not very volatile and have only had 5 moves greater than 5% over the last year. Moves this big are rare for Select Medical and indicate this news significantly impacted the market’s perception of the business.
Select Medical is down 5.4% since the beginning of the year, and at $17.77 per share, it is trading 55.8% below its 52-week high of $40.20 from November 2024. Investors who bought $1,000 worth of Select Medical’s shares 5 years ago would now be looking at an investment worth $629.92.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。